These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25082520)

  • 1. Metronomics chemotherapy: time for computational decision support.
    Barbolosi D; Ciccolini J; Meille C; Elharrar X; Faivre C; Lacarelle B; André N; Barlesi F
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):647-52. PubMed ID: 25082520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.
    Elharrar X; Barbolosi D; Ciccolini J; Meille C; Faivre C; Lacarelle B; André N; Barlesi F
    BMC Cancer; 2016 Apr; 16():278. PubMed ID: 27094927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.
    Cazzaniga ME; Camerini A; Addeo R; Nolè F; Munzone E; Collovà E; Del Conte A; Mencoboni M; Papaldo P; Pasini F; Saracchini S; Bocci G
    Future Oncol; 2016 Feb; 12(3):373-87. PubMed ID: 26584409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
    Benzekry S; Pasquier E; Barbolosi D; Lacarelle B; Barlési F; André N; Ciccolini J
    Semin Cancer Biol; 2015 Dec; 35():53-61. PubMed ID: 26361213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of metronomic chemotherapy in oncology: results from a national Italian survey.
    Collovà E; Sebastiani F; De Matteis E; Generali D; Aurilio G; Boccardo F; Crispino S; Cruciani G
    Tumori; 2011; 97(4):454-8. PubMed ID: 21989433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the time come for metronomics in low-income and middle-income countries?
    André N; Banavali S; Snihur Y; Pasquier E
    Lancet Oncol; 2013 May; 14(6):e239-48. PubMed ID: 23639324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists.
    Revon-Rivière G; Banavali S; Heississen L; Gomez Garcia W; Abdolkarimi B; Vaithilingum M; Li CK; Leung PC; Malik P; Pasquier E; Epelman S; Chantada G; André N
    J Glob Oncol; 2019 Jul; 5():1-8. PubMed ID: 31260397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vinorelbine in the treatment of non-small-cell lung cancer.
    Barletta G; Genova C; Rijavec E; Burrafato G; Biello F; Sini C; Dal Bello MG; Coco S; Truini A; Vanni I; Alama A; Beltramini S; Grassi MA; Boccardo F; Grossi F
    Expert Opin Pharmacother; 2014 Aug; 15(11):1585-99. PubMed ID: 24972635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer.
    Saridaki Z; Malamos N; Kourakos P; Polyzos A; Ardavanis A; Androulakis N; Kalbakis K; Vamvakas L; Georgoulias V; Mavroudis D
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):35-42. PubMed ID: 21590447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer.
    Briasoulis E; Pappas P; Puozzo C; Tolis C; Fountzilas G; Dafni U; Marselos M; Pavlidis N
    Clin Cancer Res; 2009 Oct; 15(20):6454-61. PubMed ID: 19808873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
    Crawford J; O'Rourke MA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metronomic chemotherapy in pediatric oncology: hype or hope?].
    André N; Pasquier E; Verschuur A; Sterba J; Gentet JC; Rössler J
    Arch Pediatr; 2009 Aug; 16(8):1158-65. PubMed ID: 19446445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
    Coltman CA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic chemotherapy from rationale to clinical studies: a dream or reality?
    Gnoni A; Silvestris N; Licchetta A; Santini D; Scartozzi M; Ria R; Pisconti S; Petrelli F; Vacca A; Lorusso V
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):46-61. PubMed ID: 25656744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.
    Traore F; Togo B; Pasquier E; Dembélé A; André N
    Indian J Cancer; 2013; 50(3):250-3. PubMed ID: 24061467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition.
    Mavroeidis L; Sheldon H; Briasoulis E; Marselos M; Pappas P; Harris AL
    Int J Oncol; 2015 Aug; 47(2):455-64. PubMed ID: 26095084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.
    Caffo O; Dipasquale M; Murgia V; Veccia A; Galligioni E
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):1037-51. PubMed ID: 23705788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
    Saloustros E; Kalbakis K; Vardakis N; Kalykaki A; Milaki G; Rovithi M; Agelaki S; Saridaki Z; Georgoulias V; Mavroudis D
    J BUON; 2011; 16(2):215-8. PubMed ID: 21766488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.